secwatch.observer — SEC 8-K summary
======================================

Issuer:     Repare Therapeutics Inc. (—)
CIK:        0001808158
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0001193125-24-118073
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Repare Therapeutics appoints Steven H. Stein to board; Todd Foley not seeking re-election
--------------------------------------------------------------------------------

- Todd Foley will not stand for re-election as Class I director at June 17, 2024 annual meeting after 7+ years.
- Steven H. Stein, M.D., appointed as Class II director effective June 2024 annual meeting.
- Dr. Stein is Chief Medical Officer of Incyte Corporation; joins Science & Technology Committee.
- Stein will receive option to purchase 54,400 common shares under standard non-employee director compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808158/000119312524118073/0001193125-24-118073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808158/000119312524118073/d798198d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-118073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer